Control Bionics Ltd
ASX:CBL
Balance Sheet
Balance Sheet Decomposition
Control Bionics Ltd
Control Bionics Ltd
Balance Sheet
Control Bionics Ltd
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2
|
1
|
1
|
12
|
5
|
1
|
1
|
1
|
|
| Cash |
2
|
1
|
1
|
12
|
5
|
1
|
1
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Assets |
2
|
1
|
2
|
14
|
9
|
4
|
4
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Intangible Assets |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
5
-14%
|
6
+17%
|
18
+189%
|
13
-27%
|
9
-35%
|
9
+4%
|
8
-9%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+74%
|
1
+66%
|
1
+91%
|
2
+27%
|
2
+2%
|
3
+78%
|
3
-1%
|
|
| Equity | |||||||||
| Common Stock |
11
|
11
|
13
|
28
|
29
|
30
|
35
|
40
|
|
| Retained Earnings |
4
|
6
|
7
|
11
|
17
|
23
|
29
|
35
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
5
-17%
|
6
+13%
|
17
+200%
|
12
-31%
|
7
-40%
|
6
-12%
|
6
-12%
|
|
| Total Liabilities & Equity |
6
N/A
|
5
-14%
|
6
+17%
|
18
+189%
|
13
-27%
|
9
-35%
|
9
+4%
|
8
-9%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
83
|
83
|
83
|
93
|
98
|
102
|
204
|
301
|
|